nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—STK10—renal artery—thoracic aortic aneurysm	0.0367	0.164	CbGeAlD
Crizotinib—EPHA2—pulmonary artery—thoracic aortic aneurysm	0.0216	0.0969	CbGeAlD
Crizotinib—RPS6KB1—leg—thoracic aortic aneurysm	0.0158	0.0707	CbGeAlD
Crizotinib—TEK—artery—thoracic aortic aneurysm	0.00782	0.035	CbGeAlD
Crizotinib—SRC—artery—thoracic aortic aneurysm	0.00695	0.0311	CbGeAlD
Crizotinib—FER—cardiac atrium—thoracic aortic aneurysm	0.00397	0.0178	CbGeAlD
Crizotinib—TIE1—cardiac atrium—thoracic aortic aneurysm	0.00371	0.0166	CbGeAlD
Crizotinib—TESK1—cardiac atrium—thoracic aortic aneurysm	0.00358	0.0161	CbGeAlD
Crizotinib—DCLK1—spinal cord—thoracic aortic aneurysm	0.00357	0.016	CbGeAlD
Crizotinib—MAP3K12—cardiac atrium—thoracic aortic aneurysm	0.00337	0.0151	CbGeAlD
Crizotinib—ACVR1—cardiac atrium—thoracic aortic aneurysm	0.00337	0.0151	CbGeAlD
Crizotinib—TYRO3—spinal cord—thoracic aortic aneurysm	0.00333	0.0149	CbGeAlD
Crizotinib—EPHA5—spinal cord—thoracic aortic aneurysm	0.00333	0.0149	CbGeAlD
Crizotinib—FER—spinal cord—thoracic aortic aneurysm	0.00333	0.0149	CbGeAlD
Crizotinib—STK35—cardiac atrium—thoracic aortic aneurysm	0.0033	0.0148	CbGeAlD
Crizotinib—RIPK2—cardiac atrium—thoracic aortic aneurysm	0.00305	0.0137	CbGeAlD
Crizotinib—TESK1—spinal cord—thoracic aortic aneurysm	0.00301	0.0135	CbGeAlD
Crizotinib—EPHA4—cardiac atrium—thoracic aortic aneurysm	0.00294	0.0132	CbGeAlD
Crizotinib—LIMK2—spinal cord—thoracic aortic aneurysm	0.00286	0.0128	CbGeAlD
Crizotinib—MAP3K12—spinal cord—thoracic aortic aneurysm	0.00283	0.0127	CbGeAlD
Crizotinib—ACVR1—spinal cord—thoracic aortic aneurysm	0.00283	0.0127	CbGeAlD
Crizotinib—TBK1—cardiac atrium—thoracic aortic aneurysm	0.00283	0.0127	CbGeAlD
Crizotinib—TYK2—cardiac atrium—thoracic aortic aneurysm	0.00281	0.0126	CbGeAlD
Crizotinib—RPS6KB1—cardiac atrium—thoracic aortic aneurysm	0.00272	0.0122	CbGeAlD
Crizotinib—AXL—cardiac atrium—thoracic aortic aneurysm	0.00269	0.0121	CbGeAlD
Crizotinib—BMP2K—spinal cord—thoracic aortic aneurysm	0.00267	0.012	CbGeAlD
Crizotinib—SLK—cardiac atrium—thoracic aortic aneurysm	0.00259	0.0116	CbGeAlD
Crizotinib—EPHB4—cardiac atrium—thoracic aortic aneurysm	0.00257	0.0115	CbGeAlD
Crizotinib—RIPK2—spinal cord—thoracic aortic aneurysm	0.00256	0.0115	CbGeAlD
Crizotinib—JAK2—cardiac atrium—thoracic aortic aneurysm	0.00256	0.0115	CbGeAlD
Crizotinib—EPHA2—cardiac atrium—thoracic aortic aneurysm	0.00252	0.0113	CbGeAlD
Crizotinib—TEK—cardiac atrium—thoracic aortic aneurysm	0.00246	0.011	CbGeAlD
Crizotinib—MAP3K3—cardiac atrium—thoracic aortic aneurysm	0.00246	0.011	CbGeAlD
Crizotinib—MAP4K5—cardiac atrium—thoracic aortic aneurysm	0.00246	0.011	CbGeAlD
Crizotinib—PTK2—spinal cord—thoracic aortic aneurysm	0.00238	0.0107	CbGeAlD
Crizotinib—TBK1—spinal cord—thoracic aortic aneurysm	0.00238	0.0107	CbGeAlD
Crizotinib—TYK2—spinal cord—thoracic aortic aneurysm	0.00236	0.0106	CbGeAlD
Crizotinib—EPHB6—cardiac atrium—thoracic aortic aneurysm	0.00235	0.0105	CbGeAlD
Crizotinib—RPS6KB1—spinal cord—thoracic aortic aneurysm	0.00229	0.0102	CbGeAlD
Crizotinib—YES1—cardiac atrium—thoracic aortic aneurysm	0.00227	0.0102	CbGeAlD
Crizotinib—AXL—spinal cord—thoracic aortic aneurysm	0.00226	0.0101	CbGeAlD
Crizotinib—TAOK3—cardiac atrium—thoracic aortic aneurysm	0.00225	0.0101	CbGeAlD
Crizotinib—SRC—cardiac atrium—thoracic aortic aneurysm	0.00219	0.00981	CbGeAlD
Crizotinib—SLK—spinal cord—thoracic aortic aneurysm	0.00218	0.00977	CbGeAlD
Crizotinib—EPHB4—spinal cord—thoracic aortic aneurysm	0.00216	0.0097	CbGeAlD
Crizotinib—JAK2—spinal cord—thoracic aortic aneurysm	0.00215	0.00963	CbGeAlD
Crizotinib—MAP4K5—spinal cord—thoracic aortic aneurysm	0.00207	0.00928	CbGeAlD
Crizotinib—MAP3K3—spinal cord—thoracic aortic aneurysm	0.00207	0.00928	CbGeAlD
Crizotinib—TEK—spinal cord—thoracic aortic aneurysm	0.00207	0.00928	CbGeAlD
Crizotinib—EPHB6—spinal cord—thoracic aortic aneurysm	0.00198	0.00887	CbGeAlD
Crizotinib—CSF1R—cardiac atrium—thoracic aortic aneurysm	0.00196	0.00881	CbGeAlD
Crizotinib—YES1—spinal cord—thoracic aortic aneurysm	0.00191	0.00857	CbGeAlD
Crizotinib—TAOK3—spinal cord—thoracic aortic aneurysm	0.00189	0.00846	CbGeAlD
Crizotinib—SRC—spinal cord—thoracic aortic aneurysm	0.00184	0.00824	CbGeAlD
Crizotinib—CSF1R—spinal cord—thoracic aortic aneurysm	0.00165	0.0074	CbGeAlD
Crizotinib—ABL1—cardiac atrium—thoracic aortic aneurysm	0.00155	0.00696	CbGeAlD
Crizotinib—ABL1—spinal cord—thoracic aortic aneurysm	0.00131	0.00585	CbGeAlD
Crizotinib—ABCB1—spinal cord—thoracic aortic aneurysm	0.000406	0.00182	CbGeAlD
Crizotinib—EPHA6—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000182	0.000234	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—ADAM10—thoracic aortic aneurysm	0.000179	0.000231	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000178	0.000229	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000178	0.000229	CbGpPWpGaD
Crizotinib—JAK3—Immune System—ADAM17—thoracic aortic aneurysm	0.000178	0.000229	CbGpPWpGaD
Crizotinib—EPHA2—Axon guidance—MMP9—thoracic aortic aneurysm	0.000177	0.000227	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000176	0.000227	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000176	0.000227	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000174	0.000224	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000173	0.000223	CbGpPWpGaD
Crizotinib—SRC—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.000172	0.000221	CbGpPWpGaD
Crizotinib—FES—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000171	0.00022	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000169	0.000218	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000169	0.000217	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000168	0.000216	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000168	0.000216	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000167	0.000215	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000165	0.000212	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000165	0.000212	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.000164	0.000211	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000162	0.000208	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000162	0.000208	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000162	0.000208	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000159	0.000205	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000159	0.000205	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—ADAM17—thoracic aortic aneurysm	0.000159	0.000205	CbGpPWpGaD
Crizotinib—SRC—EPH-Ephrin signaling—MMP9—thoracic aortic aneurysm	0.000157	0.000202	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000157	0.000202	CbGpPWpGaD
Crizotinib—LYN—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000157	0.000202	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—ADAM17—thoracic aortic aneurysm	0.000157	0.000202	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000156	0.000201	CbGpPWpGaD
Crizotinib—EPHA8—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000156	0.000201	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000156	0.000201	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000156	0.000201	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000155	0.000199	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000155	0.000199	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000155	0.000199	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000155	0.000199	CbGpPWpGaD
Crizotinib—CDK7—Disease—ADAM17—thoracic aortic aneurysm	0.000154	0.000198	CbGpPWpGaD
Crizotinib—CDK7—Disease—TGFBR1—thoracic aortic aneurysm	0.000154	0.000198	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000153	0.000197	CbGpPWpGaD
Crizotinib—BLK—Immune System—ADAM17—thoracic aortic aneurysm	0.000153	0.000197	CbGpPWpGaD
Crizotinib—FGR—Immune System—ADAM17—thoracic aortic aneurysm	0.000152	0.000196	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000152	0.000196	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000151	0.000195	CbGpPWpGaD
Crizotinib—PTK2—Immune System—PRKG1—thoracic aortic aneurysm	0.00015	0.000194	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.00015	0.000193	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00015	0.000192	CbGpPWpGaD
Crizotinib—YES1—Immune System—PRKG1—thoracic aortic aneurysm	0.000148	0.000191	CbGpPWpGaD
Crizotinib—JAK2—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000147	0.000189	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000146	0.000188	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000146	0.000188	CbGpPWpGaD
Crizotinib—PTK2—Axon guidance—MMP2—thoracic aortic aneurysm	0.000146	0.000187	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000145	0.000187	CbGpPWpGaD
Crizotinib—YES1—Axon guidance—MMP2—thoracic aortic aneurysm	0.000144	0.000185	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000143	0.000184	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—PRKG1—thoracic aortic aneurysm	0.000141	0.000181	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000139	0.000179	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—ADAM10—thoracic aortic aneurysm	0.000139	0.000179	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000138	0.000178	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000138	0.000178	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000137	0.000177	CbGpPWpGaD
Crizotinib—TYK2—Immune System—PRKG1—thoracic aortic aneurysm	0.000137	0.000176	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000137	0.000176	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000137	0.000176	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000136	0.000175	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000135	0.000174	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.000132	0.00017	CbGpPWpGaD
Crizotinib—TYK2—Axon guidance—MMP2—thoracic aortic aneurysm	0.000132	0.00017	CbGpPWpGaD
Crizotinib—LCK—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000128	0.000165	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000128	0.000165	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000127	0.000163	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000126	0.000162	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000125	0.000161	CbGpPWpGaD
Crizotinib—PTK2—Immune System—ADAM17—thoracic aortic aneurysm	0.000125	0.000161	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000124	0.00016	CbGpPWpGaD
Crizotinib—YES1—Immune System—ADAM17—thoracic aortic aneurysm	0.000123	0.000158	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000122	0.000157	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000122	0.000157	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000122	0.000157	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.00012	0.000154	CbGpPWpGaD
Crizotinib—CDK7—Disease—ADAM10—thoracic aortic aneurysm	0.000118	0.000152	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000117	0.000151	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—ADAM17—thoracic aortic aneurysm	0.000117	0.00015	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000115	0.000148	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000115	0.000148	CbGpPWpGaD
Crizotinib—SRC—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.000114	0.000146	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000113	0.000146	CbGpPWpGaD
Crizotinib—TYK2—Immune System—ADAM17—thoracic aortic aneurysm	0.000113	0.000146	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000113	0.000146	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000112	0.000144	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000111	0.000143	CbGpPWpGaD
Crizotinib—LYN—Immune System—PRKG1—thoracic aortic aneurysm	0.000111	0.000142	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000111	0.000142	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000111	0.000142	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PRKG1—thoracic aortic aneurysm	0.00011	0.000142	CbGpPWpGaD
Crizotinib—PTK2—Axon guidance—MMP9—thoracic aortic aneurysm	0.000109	0.000141	CbGpPWpGaD
Crizotinib—CDK7—Disease—TGFBR2—thoracic aortic aneurysm	0.000109	0.00014	CbGpPWpGaD
Crizotinib—YES1—Axon guidance—MMP9—thoracic aortic aneurysm	0.000108	0.000139	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—MMP2—thoracic aortic aneurysm	0.000107	0.000138	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—MMP2—thoracic aortic aneurysm	0.000107	0.000137	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000105	0.000135	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000105	0.000135	CbGpPWpGaD
Crizotinib—TYK2—Disease—ADAM17—thoracic aortic aneurysm	0.000105	0.000135	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFBR1—thoracic aortic aneurysm	0.000105	0.000135	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000104	0.000134	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—SMAD3—thoracic aortic aneurysm	0.000104	0.000134	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PRKG1—thoracic aortic aneurysm	0.000104	0.000133	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000103	0.000132	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000103	0.000132	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000103	0.000132	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000101	0.00013	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000101	0.00013	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—MMP2—thoracic aortic aneurysm	0.0001	0.000129	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.0001	0.000129	CbGpPWpGaD
Crizotinib—TYK2—Axon guidance—MMP9—thoracic aortic aneurysm	9.94e-05	0.000128	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—ADAM10—thoracic aortic aneurysm	9.91e-05	0.000128	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—SMAD3—thoracic aortic aneurysm	9.79e-05	0.000126	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	9.73e-05	0.000125	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	9.69e-05	0.000125	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	9.69e-05	0.000125	CbGpPWpGaD
Crizotinib—CDK7—Disease—SMAD3—thoracic aortic aneurysm	9.65e-05	0.000124	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	9.6e-05	0.000124	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—MMP2—thoracic aortic aneurysm	9.44e-05	0.000121	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	9.4e-05	0.000121	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	9.4e-05	0.000121	CbGpPWpGaD
Crizotinib—LYN—Immune System—ADAM17—thoracic aortic aneurysm	9.17e-05	0.000118	CbGpPWpGaD
Crizotinib—ABL1—Immune System—ADAM17—thoracic aortic aneurysm	9.13e-05	0.000117	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	9.1e-05	0.000117	CbGpPWpGaD
Crizotinib—LCK—Immune System—PRKG1—thoracic aortic aneurysm	9.07e-05	0.000117	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—MMP9—thoracic aortic aneurysm	8.95e-05	0.000115	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—ADAM10—thoracic aortic aneurysm	8.83e-05	0.000114	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	8.83e-05	0.000114	CbGpPWpGaD
Crizotinib—JAK2—Immune System—ADAM17—thoracic aortic aneurysm	8.58e-05	0.00011	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	8.17e-05	0.000105	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—SMAD3—thoracic aortic aneurysm	8.11e-05	0.000104	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	8.06e-05	0.000104	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	8.06e-05	0.000104	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—MMP9—thoracic aortic aneurysm	8.05e-05	0.000104	CbGpPWpGaD
Crizotinib—SRC—Immune System—PRKG1—thoracic aortic aneurysm	8.03e-05	0.000103	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—MMP9—thoracic aortic aneurysm	8.01e-05	0.000103	CbGpPWpGaD
Crizotinib—TYK2—Disease—ADAM10—thoracic aortic aneurysm	8.01e-05	0.000103	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	7.95e-05	0.000102	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	7.95e-05	0.000102	CbGpPWpGaD
Crizotinib—JAK2—Disease—ADAM17—thoracic aortic aneurysm	7.92e-05	0.000102	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFBR1—thoracic aortic aneurysm	7.92e-05	0.000102	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	7.87e-05	0.000101	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—MMP9—thoracic aortic aneurysm	7.81e-05	0.000101	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—MMP2—thoracic aortic aneurysm	7.77e-05	0.0001	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—ADAM10—thoracic aortic aneurysm	7.76e-05	9.99e-05	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—MMP9—thoracic aortic aneurysm	7.7e-05	9.92e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—MMP2—thoracic aortic aneurysm	7.64e-05	9.84e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—MMP2—thoracic aortic aneurysm	7.61e-05	9.79e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	7.54e-05	9.71e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	7.54e-05	9.71e-05	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—MMP9—thoracic aortic aneurysm	7.53e-05	9.7e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—ADAM17—thoracic aortic aneurysm	7.52e-05	9.67e-05	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—MMP9—thoracic aortic aneurysm	7.5e-05	9.65e-05	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—MMP9—thoracic aortic aneurysm	7.5e-05	9.65e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	7.43e-05	9.56e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFBR2—thoracic aortic aneurysm	7.41e-05	9.54e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	7.32e-05	9.42e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	7.32e-05	9.42e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	7.29e-05	9.38e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SMAD3—thoracic aortic aneurysm	7.23e-05	9.31e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	7.2e-05	9.27e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	7.18e-05	9.24e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PRKG1—thoracic aortic aneurysm	7.15e-05	9.21e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—MMP2—thoracic aortic aneurysm	7.15e-05	9.21e-05	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—MMP9—thoracic aortic aneurysm	7.11e-05	9.15e-05	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—MMP9—thoracic aortic aneurysm	7.09e-05	9.13e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—ADAM17—thoracic aortic aneurysm	6.94e-05	8.93e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFBR1—thoracic aortic aneurysm	6.94e-05	8.93e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.87e-05	8.85e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	6.7e-05	8.62e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.66e-05	8.58e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—ADAM17—thoracic aortic aneurysm	6.65e-05	8.56e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—SMAD3—thoracic aortic aneurysm	6.56e-05	8.44e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—MMP9—thoracic aortic aneurysm	6.5e-05	8.37e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	6.45e-05	8.3e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SMAD3—thoracic aortic aneurysm	6.35e-05	8.18e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	6.18e-05	7.95e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—ADAM17—thoracic aortic aneurysm	6.14e-05	7.91e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFBR1—thoracic aortic aneurysm	6.14e-05	7.91e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	6.09e-05	7.84e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	6.08e-05	7.82e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—ADAM10—thoracic aortic aneurysm	6.07e-05	7.82e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ADAM17—thoracic aortic aneurysm	5.93e-05	7.63e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	5.93e-05	7.63e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.89e-05	7.59e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PRKG1—thoracic aortic aneurysm	5.86e-05	7.55e-05	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—MMP9—thoracic aortic aneurysm	5.84e-05	7.52e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	5.78e-05	7.44e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—MMP9—thoracic aortic aneurysm	5.75e-05	7.39e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—MMP9—thoracic aortic aneurysm	5.72e-05	7.36e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.72e-05	7.36e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—MMP9—thoracic aortic aneurysm	5.68e-05	7.31e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.64e-05	7.26e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFBR2—thoracic aortic aneurysm	5.62e-05	7.23e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	5.61e-05	7.22e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	5.55e-05	7.14e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	5.55e-05	7.14e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP2—thoracic aortic aneurysm	5.55e-05	7.14e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—MMP9—thoracic aortic aneurysm	5.38e-05	6.92e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.35e-05	6.88e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—ADAM10—thoracic aortic aneurysm	5.32e-05	6.85e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PRKG1—thoracic aortic aneurysm	5.19e-05	6.68e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.19e-05	6.68e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—MMP9—thoracic aortic aneurysm	5.14e-05	6.61e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.06e-05	6.51e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—MMP9—thoracic aortic aneurysm	5.03e-05	6.47e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.99e-05	6.42e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—SMAD3—thoracic aortic aneurysm	4.97e-05	6.4e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFBR2—thoracic aortic aneurysm	4.92e-05	6.33e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	4.86e-05	6.25e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ADAM17—thoracic aortic aneurysm	4.86e-05	6.25e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.73e-05	6.09e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—ADAM10—thoracic aortic aneurysm	4.71e-05	6.06e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.59e-05	5.91e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.54e-05	5.85e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFBR2—thoracic aortic aneurysm	4.36e-05	5.61e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—SMAD3—thoracic aortic aneurysm	4.35e-05	5.6e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADAM17—thoracic aortic aneurysm	4.3e-05	5.54e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	4.3e-05	5.54e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.25e-05	5.47e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	4.2e-05	5.41e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP9—thoracic aortic aneurysm	4.17e-05	5.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.93e-05	5.06e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—SMAD3—thoracic aortic aneurysm	3.85e-05	4.96e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ADAM10—thoracic aortic aneurysm	3.72e-05	4.79e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.72e-05	4.79e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.72e-05	4.78e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.48e-05	4.48e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.45e-05	4.44e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.31e-05	4.26e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADAM10—thoracic aortic aneurysm	3.3e-05	4.24e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.26e-05	4.2e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.12e-05	4.02e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.05e-05	3.93e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.05e-05	3.92e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.03e-05	3.9e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SMAD3—thoracic aortic aneurysm	2.7e-05	3.47e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.6e-05	3.34e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.56e-05	3.3e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.43e-05	3.13e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.36e-05	3.04e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.91e-05	2.46e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.79e-05	2.3e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.57e-05	2.02e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.39e-05	1.78e-05	CbGpPWpGaD
